Acer Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	202.78	220.03	276.56
Cash & Short-Term Investments	202.78	220.03	276.56
Cash Growth	-7.84%	-20.44%	-
Accounts Receivable	10.74	15.29	4.56
Other Receivables	1.71	2.18	1.1
Receivables	12.45	17.47	5.66
Inventory	3.72	12.13	-
Prepaid Expenses	1.95	0.22	0.46
Other Current Assets	-	0	-
Total Current Assets	220.89	249.86	282.68
Property, Plant & Equipment	1.82	2.39	3.12
Other Intangible Assets	3.87	4.53	4.36
Other Long-Term Assets	0.31	2.65	-
Total Assets	226.89	259.43	290.16
Accounts Payable	1.73	8.42	0.86
Accrued Expenses	27.38	26.64	15.96
Current Unearned Revenue	0.24	0.01	-
Other Current Liabilities	2.96	2.42	13.22
Total Current Liabilities	32.3	37.49	30.04
Total Liabilities	32.3	37.49	30.04
Common Stock	152.26	152.26	152.26
Additional Paid-In Capital	203.79	203.78	203.78
Retained Earnings	-161.46	-134.1	-95.92
Shareholders' Equity	194.59	221.94	260.12
Total Liabilities & Equity	226.89	259.43	290.16
Net Cash (Debt)	202.78	220.03	276.56
Net Cash Growth	-7.84%	-20.44%	-
Net Cash Per Share	13.32	14.45	22.42
Filing Date Shares Outstanding	15.23	15.23	12.67
Total Common Shares Outstanding	15.23	15.23	12.67
Working Capital	188.59	212.37	252.64
Book Value Per Share	12.78	14.58	20.53
Tangible Book Value	190.72	217.4	255.76
Tangible Book Value Per Share	12.53	14.28	20.18
Machinery	3.63	3.63	3.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.